Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about PURETECH HEALTH PLC
01/29RESTORBIO : BioCentury - resTORbio raises $85M IPO
AQ
01/26PURETECH HEALTH : Affiliate resTORbio Announces Pricing of Initial Public Offeri..
PU
01/03PURETECH HEALTH : Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice Pr..
PU
01/03PURETECH HEALTH : resTORbio Appoints Lynne Sullivan to Its Board of Directors
BU
01/02PURETECH HEALTH : Affiliate resTORbio Files Public Registration Statement for Pr..
PU
2017PURETECH HEALTH : Affiliate Entrega to Receive $5 Million for Eli Lilly Collabor..
DJ
2017PURETECH HEALTH : Entrega To Receive $5 Million Investment from Lilly To Advance..
PU
2017ENTREGA : To Receive $5 Million Investment from Lilly To Advance Proprietary Ora..
BU
2017PURETECH HEALTH : Vedanta Biosciences Granted Four New US Patents Expanding Cove..
PU
2017VEDANTA BIOSCIENCES : Granted Four New U.S. Patents Expanding Coverage for Compo..
BU
2017PURETECH HEALTH : resTORbio Appoints Paul Fonteyne to Its Board of Directors
BU
2017PURETECH HEALTH : Affiliate resTORbio Adds Paul Fonteyne, CEO of Boehringer Inge..
PU
2017PURETECH HEALTH : Microbiome Programme Advances into a Phase 1a/1b Clinical Tria..
PU
2017VEDANTA BIOSCIENCES : Announces Initiation of Phase 1a/1b Trial for New Drug Cla..
BU
2017PURETECH HEALTH : resTORbio Files Confidential Submission of Draft Registration ..
PU
More most relevant news
All news about PURETECH HEALTH PLC
01/29RESTORBIO : BioCentury - resTORbio raises $85M IPO
AQ
01/26PURETECH HEALTH : Affiliate resTORbio Announces Pricing of Initial Public Offeri..
PU
01/03PURETECH HEALTH : Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice Pr..
PU
01/03PURETECH HEALTH : resTORbio Appoints Lynne Sullivan to Its Board of Directors
BU
01/02PURETECH HEALTH : Affiliate resTORbio Files Public Registration Statement for Pr..
PU
2017PURETECH HEALTH : Affiliate Entrega to Receive $5 Million for Eli Lilly Collabor..
DJ
2017PURETECH HEALTH : Entrega To Receive $5 Million Investment from Lilly To Advance..
PU
2017ENTREGA : To Receive $5 Million Investment from Lilly To Advance Proprietary Ora..
BU
2017PURETECH HEALTH : Vedanta Biosciences Granted Four New US Patents Expanding Cove..
PU
2017VEDANTA BIOSCIENCES : Granted Four New U.S. Patents Expanding Coverage for Compo..
BU
More news
Sector news : Biotechnology & Medical Research - NEC
02/23SANOFI : Says U.S. Waiting Period for Bioverativ Has Expired
DJ
02/22SANGAMO THERAPEUTICS : Surges on Therapy Collaboration Deal with Kite -- Market ..
DJ
02/22Sangamo in $3 billion gene-editing deal with Gilead
RE
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
02/23“The era of political correctness is over.” –Ben Shapiro #CPAC2018
318
02/23Conservative commentator Ben Shapiro on Thursday told activists that the “era..
375
02/23National group threatens to sue U of M over Ben Shapiro event location
3
02/23Kaboom! Dismantles Liberal Media as 'Vile Human Beings' for Smearing Conserv..
52
02/23Kaboom! Dismantles Liberal Media as 'Vile Human Beings' for Smearing Conserv..
27
More tweets
Qtime:65
Financials ($)
Sales 2017 1,58 M
EBIT 2017 -121 M
Net income 2017 -89,8 M
Finance 2017 23,9 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 348x
EV / Sales 2018 160x
Capitalization 572 M
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,49 $
Spread / Average Target 46%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC13.33%572
CELLTRION, INC.--.--%34 966
IQVIA HOLDINGS INC1.90%20 749
LONZA GROUP-6.95%19 587
INCYTE CORPORATION-10.56%17 877
NEKTAR THERAPEUTICS44.76%13 613